Apoptosis and non-alcoholic fatty liver diseases
Open accessThe DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Abstract
The number of patients with nonalcoholic fatty liver diseases (NAFLD) including nonalcoholic steatohepatitis (NASH), has been increasing. NASH causes cirrhosis and hepatocellular carcinoma (HCC) and is one of the most serious health problems in the world. The mechanism through which NASH progresses is still largely unknown. Activation of caspases, Bcl-2 family proteins, and c-Jun N-terminal kinase-induced hepatocyte apoptosis plays a role in the activation of NAFLD/NASH. Apoptotic hepatocytes stimulate immune cells and hepatic stellate cells toward the progression of fibrosis in the liver through the production of inflammasomes and cytokines. Abnormalities in glucose and lipid metabolism as well as microbiota accelerate these processes. The production of reactive oxygen species, oxidative stress, and endoplasmic reticulum stress is also involved. Cell death, including apoptosis, seems very important in the progression of NAFLD and NASH. Recently, inhibitors of apoptosis have been developed as drugs for the treatment of NASH and may prevent cirrhosis and HCC. Increased hepatocyte apoptosis may distinguish NASH from NAFLD, and the improvement of apoptosis could play a role in controlling the development of NASH. In this review, the association between apoptosis and NAFLD/NASH are discussed. This review could provide their knowledge, which plays a role in seeing the patients with NAFLD/NASH in daily clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ferreira, D. M. S., Castro, R. E., Machado, M. V., Evangelista, T., Silvestre, A. R., Costa, A., Coutinho, J. R. H., Carepa, F., Cortez‐Pinto, H., & Rodrigues, C. M. P. (2011) · Diabetologia · doi:10.1007/s00125-011-2130-8 · Cited by 108
RetractedNonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis
Malhi, H., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510660200 · Cited by 722
Feldstein, A. E., Wieckowska, A., Lopez, R. A., Liu, Y.-C., Zein, N. N., & McCullough, A. J. (2009) · Hepatology · doi:10.1002/hep.23050 · Cited by 712
Wieckowska, A., Zein, N. N., Yerian, L. M., Lopez, R. A., McCullough, A. J., & Feldstein, A. E. (2006) · Hepatology · doi:10.1002/hep.21223 · Cited by 670
Current and future pharmacological therapies for NAFLD/NASH
Sumida, Y., & Yoneda, M. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1415-1 · Cited by 667
Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24341 · Cited by 645
The epidemiology of non‐alcoholic fatty liver disease
Bellentani, S. (2017) · Liver International · doi:10.1111/liv.13299 · Cited by 606
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Mota, M., Banini, B. A., Cazanave, S. C., & Sanyal, A. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.014 · Cited by 570
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes
Hirsova, P., Ibrahim, S. H., Krishnan, A., Verma, V. K., Bronk, S. F., Werneburg, N. W., Charlton, M. R., Shah, V. H., Malhi, H., & Gores, G. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.037 · Cited by 507
Tomita, K., Tamiya, G., Ando, S., Ohsumi, K., Chiyo, T., Mizutani, A., Kitamura, N., Toda, K., Kaneko, T., Horie, Y., et al. (2006) · Gut · doi:10.1136/gut.2005.071118 · Cited by 438
Self-citationLi, H., Fang, Q., Gao, F., Fan, J., Zhou, J., Wang, X., Zhang, H., Pan, X., Bao, Y., Xiang, K., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.018 · Cited by 399
Ribeiro, P. S., Cortez-Pinto, H., Solá, S., Castro, R. E., Ramalho, R. M., Baptista, A., Moura, M. C., Camilo, M. E., & Rodrigues, C. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40009.x · Cited by 395
Tanaka, S., Hikita, H., Tatsumi, T., Sakamori, R., Nozaki, Y., Sakane, S., Shiode, Y., Nakabori, T., Saito, Y., Hiramatsu, N., et al. (2016) · Hepatology · doi:10.1002/hep.28820 · Cited by 376
Castro, R. E., Ferreira, D. M. S., Afonso, M. B., Borralho, P. M., Machado, M. V., Cortez-Pinto, H., & Rodrigues, C. M. P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.008 · Cited by 350
Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
Van Rooyen, D. M., Larter, C. Z., Haigh, W. G., Yeh, M. M., Ioannou, G., Kuver, R., Lee, S. P., Teoh, N. C., & Farrell, G. C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.040 · Cited by 345
A positive feedback loop between RIP3 and JNK controls non‐alcoholic steatohepatitis
Gautheron, J., Vucur, M., Reisinger, F., Cardenas, D. V., Roderburg, C., Koppe, C., Kreggenwinkel, K., Schneider, A. T., Bartneck, M., Neumann, U. P., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201403856 · Cited by 314
Yang, L., Roh, Y. S., Song, J., Zhang, B., Liu, C., Loomba, R., & Seki, E. (2014) · Hepatology · doi:10.1002/hep.26698 · Cited by 275
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
Hirsova, P., Ibrabim, S. H., Gores, G. J., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066357 · Cited by 270
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
Alkhouri, N., Carter-Kent, C., & Feldstein, A. E. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.6 · Cited by 254
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis #
Witek, R. P., Stone, C. W., Karaca, G. F., Syn, W.-K., Pereira, T. A., Agboola, K. M., Omenetti, A., Jung, Y., Teaberry, V., Choi, S. S., et al. (2009) · Hepatology · doi:10.1002/hep.23167 · Cited by 253
Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells
Wobser, H., Dorn, C., Weiss, T. S., Amann, T., Bollheimer, C., Büttner, R., Schölmerich, J., & Hellerbrand, C. (2009) · Cell Research · doi:10.1038/cr.2009.73 · Cited by 238
Kim, S. H., Kim, G., Han, D. H., Lee, M., Kim, I., Kim, B., Kim, K. H., Song, Y.-M., Yoo, J. E., Wang, H. J., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1356977 · Cited by 222
Sharma, R. S., Harrison, D. J., Kisielewski, D., Cassidy, D. M., McNeilly, A. D., Gallagher, J. R., Walsh, S. V., Honda, T., McCrimmon, R. J., Dinkova-Kostova, A. T., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.11.016 · Cited by 213
Gan, L. T., Van Rooyen, D. M., Koina, M. E., McCuskey, R. S., Teoh, N. C., & Farrell, G. C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.024 · Cited by 198
The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
Liang, S., Kisseleva, T., & Brenner, D. A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00017 · Cited by 197
Derdak, Z., Villegas, K. A., Harb, R., Wu, A. M., Sousa, A., & Wands, J. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.042 · Cited by 193
Zhang, P., Wang, P.-X., Zhao, L.-P., Zhang, X., Ji, Y.-X., Zhang, X.-J., Fang, C., Lu, Y.-X., Yang, X., Gao, M.-M., et al. (2018) · Nature Medicine · doi:10.1038/nm.4453 · Cited by 188
Activation of the complement system in human nonalcoholic fatty liver disease†
Rensen, S. S., Slaats, Y., Driessen, A., Peutz‐Kootstra, C. J., Nijhuis, J., Steffensen, R., Greve, J. W., & Buurman, W. A. (2009) · Hepatology · doi:10.1002/hep.23228 · Cited by 165
Apoptotic Caspases: Multiple or Mistaken Identities?
McArthur, K., & Kile, B. T. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.003 · Cited by 162
Bieghs, V., Wouters, K., van Gorp, P. J., Gijbels, M. J. J., de Winther, M. P. J., Binder, C. J., Lütjohann, D., Febbraio, M., Moore, K. J., van Bilsen, M., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.051 · Cited by 160
Nobili, V., Carpino, G., Alisi, A., Franchitto, A., Alpini, G. D., Vito, R. D., Onori, P., Alvaro, D., & Gaudio, E. (2012) · Hepatology · doi:10.1002/hep.25742 · Cited by 160
Egnatchik, R. A., Leamy, A. K., Jacobson, D. A., Shiota, M., & Young, J. D. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.05.004 · Cited by 160
Anstee, Q. M., Concas, D., Kudo, H., Levene, A., Pollard, J., Charlton, P., Thomas, H. C., Thursz, M. R., & Goldin, R. D. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.016 · Cited by 158
Receptor interacting protein 3 protects mice from high‐fat diet‐induced liver injury
Roychowdhury, S., McCullough, R. L., Sanz‐Garcia, C., Saikia, P., Alkhouri, N., Matloob, A., Pollard, K. A., McMullen, M. R., Croniger, C. M., & Nagy, L. E. (2016) · Hepatology · doi:10.1002/hep.28676 · Cited by 153
Kudo, H., Takahara, T., Yata, Y., Kawai, K., Zhang, W., & Sugiyama, T. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.02.032 · Cited by 152
Pulli, B., Ali, M., Iwamoto, Y., Zeller, M. W. G., Schob, S., Linnoila, J. J., & Chen, J. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6108 · Cited by 143
Willy, J. A., Young-Baird, S. K., Stevens, J. L., Masuoka, H. C., & Wek, R. C. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-01-0036 · Cited by 141
E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis
Denechaud, P.-D., Lopez-Mejia, I. C., Giralt, A., Lai, Q., Blanchet, E., Delacuisine, B., Nicolay, B. N., Dyson, N. J., Bonner, C., Pattou, F., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81542 · Cited by 141
Win, S., Than, T. A., Le, B. H. A., García-Ruiz, C., Fernandez-Checa, J. C., & Kaplowitz, N. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.032 · Cited by 140
Ikura, Y., Ohsawa, M., Suekane, T., Fukushima, H., Itabe, H., Jomura, H., Nishiguchi, S., Inoue, T., Naruko, T., Ehara, S., et al. (2006) · Hepatology · doi:10.1002/hep.21070 · Cited by 140
Li, S., Dou, X., Ning, H., Song, Q., Wei, W., Zhang, X., Shen, C., Li, J., Sun, C., & Song, Z. (2017) · Hepatology · doi:10.1002/hep.29229 · Cited by 129
Tomita, K., Teratani, T., Suzuki, T., Oshikawa, T., Yokoyama, H., Shimamura, K., Nishiyama, K., Mataki, N., Irie, R., Minamino, T., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.013 · Cited by 127
工藤, 浩. (2009) · Medical Entomology and Zoology · Cited by 124
Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents
Hatting, M., Zhao, G., Schumacher, F., Sellge, G., Masaoudi, M. A., Gaβler, N., Boekschoten, M., Müller, M., Liedtke, C., Cubero, F. J., et al. (2013) · Hepatology · doi:10.1002/hep.26271 · Cited by 119
Kahraman, A., Schlattjan, M., Kocabayoglu, P., Yildiz-Meziletoglu, S., Schlensak, M., Fingas, C. D., Wedemeyer, I., Marquitan, G., Gieseler, R. K., Baba, H. A., et al. (2010) · Hepatology · doi:10.1002/hep.23253 · Cited by 116
Kazankov, K., Barrera, F., Møller, H. J., Rosso, C., Bugianesi, E., David, E., Ibrahim Kamal Jouness, R., Esmaili, S., Eslam, M., McLeod, D., et al. (2016) · Liver International · doi:10.1111/liv.13150 · Cited by 113
miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
Rodrigues, P. M., Afonso, M. B., Simão, A. L., Carvalho, C. C., Trindade, A., Duarte, A., Borralho, P. M., Machado, M. V., Cortez-Pinto, H., Rodrigues, C. M., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.172 · Cited by 113
Zhang, J., Zhang, H., Deng, X., Zhang, N., Liu, B., Xin, S., Li, G., & Xu, K. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.027 · Cited by 106
Machado, M. V., Michelotti, G. A., Pereira, T. D. A., Boursier, J., Kruger, L., Swiderska-Syn, M., Karaca, G., Xie, G., Guy, C. D., Bohinc, B., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307362 · Cited by 103
García‐Monzón, C., Iacono, O. L., Mayoral, R., González‐Rodríguez, Á., Miquilena-Colina, M. E., Lozano-Rodríguez, T., García-Pozo, L., Vargas‐Castrillón, J., Casado, M., Boscá, L., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.021 · Cited by 103
Haczeyni, F., Wang, H., Barn, V., Mridha, A. R., Yeh, M. M., Haigh, W. G., Ioannou, G. N., Choi, Y., McWherter, C. A., Teoh, N. C. ‐., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1072 · Cited by 101
Gandhi, C. R., Chaillet, J. R., Nalesnik, M. A., Kumar, S., Dangi, A., Demetris, A. J., Ferrell, R., Wu, T., Divanovic, S., Stankeiwicz, T., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.008 · Cited by 99
TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess
Idrissova, L., Malhi, H., Werneburg, N. W., LeBrasseur, N. K., Bronk, S. F., Fingas, C., Tchkonia, T., Pirtskhalava, T., White, T. A., Stout, M. B., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.033 · Cited by 95
Giannini, C., Feldstein, A. E., Santoro, N., Kim, G., Kursawe, R., Pierpont, B., & Caprio, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1250 · Cited by 95
A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA
Cazanave, S. C., Mott, J. L., Elmi, N. A., Bronk, S. F., Masuoka, H. C., Charlton, M. R., & Gores, G. J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014654 · Cited by 93
Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis
Ramalho, R. M., Cortez-Pinto, H., Castro, R. E., Sol??, S., Costa, A., Moura, M. C., Camilo, M. E., & Rodrigues, C. M. P. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200601000-00005 · Cited by 89
New insights into the functions and localization of nuclear transglutaminase 2
Kuo, T., Tatsukawa, H., & Kojima, S. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08409.x · Cited by 87
Maliken, B. D., Nelson, J. E., Klintworth, H. M., Beauchamp, M., Yeh, M. M., & Kowdley, K. V. (2013) · Hepatology · doi:10.1002/hep.26238 · Cited by 86
Baranova, A., Tran, T. P., Afendy, A., Wang, L., Shamsaddini, A., Mehta, R., Chandhoke, V., Birerdinc, A., & Younossi, Z. M. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-133 · Cited by 85
Daugherity, E. K., Balmus, G., Al Saei, A., Moore, E. S., Abi Abdallah, D., Rogers, A. B., Weiss, R. S., & Maurer, K. J. (2012) · Cell Cycle · doi:10.4161/cc.20259 · Cited by 81
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis
Ibrahim, S. H., Akazawa, Y., Cazanave, S. C., Bronk, S. F., Elmi, N. A., Werneburg, N. W., Billadeau, D. D., & Gores, G. J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.039 · Cited by 81
Kuo, T., Tatsukawa, H., Matsuura, T., Nagatsuma, K., Hirose, S., & Kojima, S. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22833 · Cited by 81
Palmitic acid induces autophagy in hepatocytes via JNK2 activation
Tu, Q., Zheng, R., Li, J., Hu, L., Chang, Y., Li, L., Li, M., Wang, R., Huang, D., Wu, M., et al. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.170 · Cited by 81
Autophagy protects against palmitate-induced apoptosis in hepatocytes
Cai, N., Zhao, X., Jing, Y., Sun, K., Jiao, S., Chen, X., Yang, H., Zhou, Y., & Wei, L. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-28 · Cited by 78
Hajighasem, A., Farzanegi, P., & Mazaheri, Z. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1441872 · Cited by 76
Kroy, D. C., Schumacher, F., Ramadori, P., Hatting, M., Bergheim, I., Gaßler, N., Boekschoten, M. V., Müller, M. M., Streetz, K. L., & Trautwein, C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.019 · Cited by 73
Locatelli, I., Sutti, S., Vacchiano, M., Bozzola, C., & Albano, E. (2013) · Clinical Science · doi:10.1042/cs20120289 · Cited by 67
Yin, X., Zheng, F., Pan, Q., Zhang, S., Yu, D., Xu, Z., & Li, H. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0101 · Cited by 67
Toriguchi, K., Hatano, E., Tanabe, K., Takemoto, K., Nakamura, K., Koyama, Y., Seo, S., Taura, K., & Üemoto, S. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12481 · Cited by 65
A hedgehog survival pathway in ‘undead’ lipotoxic hepatocytes
Kakisaka, K., Cazanave, S. C., Werneburg, N. W., Razumilava, N., Mertens, J. C., Bronk, S. F., & Gores, G. J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.011 · Cited by 65
Zhang, W., Kudo, H., Kawai, K., Fujisaka, S., Usui, I., Sugiyama, T., Tsukada, K., Chen, N., & Takahara, T. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.144 · Cited by 62
Henkel, J., Coleman, C. D., Schraplau, A., Jöhrens, K., Weber, D., Castro, J. P., Hugo, M., Schulz, T. J., Krämer, S., Schürmann, A., et al. (2017) · Molecular Medicine · doi:10.2119/molmed.2016.00203 · Cited by 62
Gomez-Santos, L., Luka, Z., Wagner, C., Fernandez-Alvarez, S., Lu, S. C., Mato, J. M., Martinez-Chantar, M. L., & Beraza, N. (2012) · Hepatology · doi:10.1002/hep.25694 · Cited by 61
Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis
Povero, D., & Feldstein, A. E. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.1.1 · Cited by 60
Hepatoprotective potential of isoquercitrin against type 2 diabetes-induced hepatic injury in rats
Huang, X., He, Y., Ji, L.-L., Wang, K., Wang, Y., Chen, D., Geng, Y., Ouyang, P., & Lai, W. (2017) · Oncotarget · doi:10.18632/oncotarget.21074 · Cited by 59
Liver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitis
Eguchi, A., De Mollerat Du Jeu, X., Johnson, C. D., Nektaria, A., & Feldstein, A. E. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.002 · Cited by 58
Liu, X., Henkel, A. S., LeCuyer, B. E., Schipma, M. J., Anderson, K. A., & Green, R. M. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00132.2015 · Cited by 58
Ao, N., Yang, J., Wang, X., & Du, J. (2016) · Hepatology Research · doi:10.1111/hepr.12551 · Cited by 56
Ibrahim, S. H., Gores, G. J., Hirsova, P., Kirby, M., Miles, L., Jaeschke, A., & Kohli, R. (2014) · Liver International · doi:10.1111/liv.12353 · Cited by 54
Roles of Fas/Fasl, Bcl-2/Bax, and Caspase-8 in rat nonalcoholic fatty liver disease pathogenesis
Li, C. P., Li, J. H., He, S. Y., Li, P., & Zhong, X. L. (2014) · Genetics and Molecular Research · doi:10.4238/2014.may.23.10 · Cited by 54
Huang, F., Wang, J., Yu, F., Tang, Y., Ding, G., Yang, Z., & Sun, Y. (2018) · Marine Drugs · doi:10.3390/md16020039 · Cited by 54
Williams, K., de Ribeiro, A. J. V., Prakoso, E., Veillard, A., Shackel, N. A., Brooks, B. A., Bu, Y., Cavanagh, E., Raleigh, J., McLennan, S. V., et al. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12237 · Cited by 53
Clinical implications of understanding the association between oxidative stress and pediatric NAFLD
Mann, J. P., Raponi, M., & Nobili, V. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1291340 · Cited by 51
Metabolomic Profiling Reveals a Role for Caspase-2 in Lipoapoptosis
Johnson, E. S., Lindblom, K., Robeson, A. C., Stevens, R. D., Ilkayeva, O., Newgard, C. B., Kornbluth, S. A., & Andersen, J. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437210 · Cited by 50
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
Machado, M. V., & Cortez-Pinto, H. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.16 · Cited by 50
KIRSCH, R., CLARKSON, V., VERDONK, R. C., MARAIS, A. D., SHEPHARD, E. G., RYFFEL, B., & DE LA M HALL, P. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04220.x · Cited by 49
Kücükoglu, Ö., Güldiken, N., Chen, Y., Usachov, V., Heliebi, A. E., Haybaeck, J., Denk, H., Trautwein, C., & Strnad, P. (2014) · Hepatology · doi:10.1002/hep.27068 · Cited by 47
HIF‐1α Expression as a Protective Strategy of HepG2 Cells Against Fatty Acid‐Induced Toxicity
Yoo, W., Noh, K. H., Ahn, J. H., Yu, J. H., Seo, J. A., Kim, S. G., Choi, K. M., Baik, S. H., Choi, D. S., Kim, T. W., et al. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24757 · Cited by 47
Triggering of Parkin Mitochondrial Translocation in Mitophagy: Implications for Liver Diseases
Eid, N. A. S., Ito, Y., & Otsuki, Y. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00100 · Cited by 47
Cartland, S. P., Harith, H. H., Genner, S. W., Dang, L., Cogger, V. C., Vellozzi, M., Bartolo, B. A. D., Thomas, S. R., Adams, L. A., & Kavurma, M. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01721-4 · Cited by 45
Dechandt, C. R. P., dos Reis, F. H. Z., Teodoro, B. G., Fernandes, A. M. A. P., Eberlin, M. N., Kettelhut, Í. D. C., Curti, C., & Alberici, L. C. (2017) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-017-9725-9 · Cited by 45
Xu, Z., Zhang, X., Lau, J. K. C., & Yu, J. Q. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.16 · Cited by 44
Nakamura, M., Kanda, T., Sasaki, R., Haga, Y., Jiang, X., Wu, S., Nakamoto, S., & Yokosuka, O. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144295 · Cited by 43
Self-citationThe involvement of NLRX1 and NLRP3 in the development of nonalcoholic steatohepatitis in mice
Wang, Y., Fang, W., Wei, J., Wang, T., Wang, N., Ma, J., & Shi, M. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.08.010 · Cited by 42
Hsieh, S., Leaderer, B. P., Feldstein, A. E., Santoro, N., McKay, L. A., Caprio, S., & McConnell, R. (2017) · Pediatric Obesity · doi:10.1111/ijpo.12228 · Cited by 41
Aparicio-Vergara, M., Hommelberg, P. P. H., Schreurs, M., Gruben, N., Stienstra, R., Shiri-Sverdlov, R., Kloosterhuis, N. J., de Bruin, A., van de Sluis, B., Koonen, D. P. Y., et al. (2013) · Hepatology · doi:10.1002/hep.26046 · Cited by 40
Mmu-miR-615-3p Regulates Lipoapoptosis by Inhibiting C/EBP Homologous Protein
Miyamoto, Y., Mauer, A. S., Kumar, S., Mott, J. L., & Malhi, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109637 · Cited by 39
Xiao, F., Waldrop, S. L., Bronk, S. F., Gores, G. J., Davis, L. S., & Kilic, G. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9456-5 · Cited by 38
The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance
Zhang, Q., Zhao, L., Tian, X., Yan, C., Li, Y., Liu, Y., Wang, P., Zhang, X., & Han, Y. (2017) · Hepatology · doi:10.1002/hep.29257 · Cited by 38
Koyama, N., Yamazaki, T., Kanetsuki, Y., Hirota, J., Asai, T., Mitsumoto, Y., Mizuno, M., Shima, T., Kanbara, Y., Arai, S., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1398-y · Cited by 38
Alkhouri, N., Alisi, A., Okwu, V., Matloob, A., Ferrari, F., Crudele, A., Vito, R. D., López, R., Feldstein, A. E., & Nobili, V. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3614-z · Cited by 36
Cheng, Q., Li, N., Chen, M., Zheng, J., Qian, Z., Wang, X., Huang, C., Xu, S., & Shi, G. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2823-6 · Cited by 35
Seeßle, J., Liebisch, G., Schmitz, G., Stremmel, W., & Chamulitrat, W. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.01.004 · Cited by 34
Ouyang, Q., Xuan, C.-X., Wang, X., Luo, H.-Q., Liu, J.-E., Wang, L.-L., Li, T.-T., Chen, Y.-P., & Liu, J. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.142 · Cited by 33
LUBAC Formation Is Impaired in the Livers of Mice with MCD‐Dependent Nonalcoholic Steatohepatitis
Matsunaga, Y., Nakatsu, Y., Fukushima, T., Okubo, H., Iwashita, M., Sakoda, H., Fujishiro, M., Yamamotoya, T., Kushiyama, A., Takahashi, S., et al. (2015) · Mediators of Inflammation · doi:10.1155/2015/125380 · Cited by 32
Xie, F., Jia, L., Lin, M., Shi, Y., Yin, J., Liu, Y., Chen, D., & Meng, Q. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12364 · Cited by 30
The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis
Lee, S. J., Yoo, J. D., Choi, S. Y., & Kwon, O. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.8.256 · Cited by 30
Treatment options for nonalcoholic steatohepatitis - a safety evaluation
Issa, D., Wattacheril, J. J., & Sanyal, A. J. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1343299 · Cited by 30
Wu, R., Nakatsu, G., Zhang, X., & Yu, J. Q. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1125883 · Cited by 29
Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis
Huo, J., Ma, Y., Liu, J.-J., Ho, Y. S., Liu, S., Soh, L., Chen, S., Xu, S., Han, W., Hong, A., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.12 · Cited by 27
Mechanism of the promotion of steatotic HepG2 cell apoptosis by cholesterol.
Zhu, C., Xie, P., Zhao, F., Zhang, L., An, W., & Zhan, Y. (2014) · PubMed · Cited by 26
Non-Alcoholic Steatohepatitis Pathogenesis: Role of Repair in Regulating the Disease Progression
Jung, Y., & Diehl, A. M. (2010) · Digestive Diseases · doi:10.1159/000282092 · Cited by 26
Uncoupling Protein 2 Regulates Palmitic Acid-Induced Hepatoma Cell Autophagy
Lou, J., Wang, Y., Wang, X., & Jiang, Y. (2014) · BioMed Research International · doi:10.1155/2014/810401 · Cited by 25
Kondo, Y., & Ishigami, A. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12722 · Cited by 23
Degradation of cIAPs contributes to hepatocyte lipoapoptosis
Akazawa, Y., Guicciardi, M. E., Cazanave, S. C., Bronk, S. F., Werneburg, N. W., Kakisaka, K., Nakao, K., & Gores, G. J. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00111.2013 · Cited by 22
Machado, M. V., Krüger, L., Jewell, M. L., Michelotti, G. A., Pereira, T. A., Xie, G., Moylan, C. A., & Diehl, A. M. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3871-x · Cited by 22
Park, S., Kim, J., Yun, H., Choi, S., Lee, S. H., Choi, K., Lim, C. W., Lee, K., & Kim, B. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.05.012 · Cited by 21
Farnesoid X Receptor (FXR) from normal to malignant state.
Koutsounas, I., Giaginis, C., & Theocharis, S. (2012) · Histology and Histopathology · doi:10.14670/hh-27.835 · Cited by 20
Shi, T., Yang, X., Zhou, H., Xi, J., Sun, J., Ke, Y., Zhang, J., Shao, Y., Jiang, X., Pan, X., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189856 · Cited by 19
Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis
Jin, X., Liu, J., Chen, Y., Xiang, Z., Ding, J., & Li, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174218 · Cited by 14
Highly expressed MT-ND3 positively associated with histological severity of hepatic steatosis
Wang, H., Chen, H., Chen, K., Xiao, J.-F., He, K., Xiang, G., & Xie, X. (2013) · Apmis · doi:10.1111/apm.12166 · Cited by 12
KEAP the balance between life and death
Cazanave, S. C., & Sanyal, A. J. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.968065 · Cited by 8
Cited by
Tran, S., Baba, I., Poupel, L., Dussaud, S., Moreau, M., Gélineau, A., Marcelin, G., Magréau-Davy, E., Ouhachi, M., Lesnik, P., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.003 · Cited by 400
High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms
Lian, C.-Y., Zhai, Z.-Z., Li, Z.-F., & Wang, L. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109199 · Cited by 302
Updated mechanisms of MASLD pathogenesis
Li, Y., Yang, P., Ye, J., Xu, Q., Wu, J., & Wang, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02108-x · Cited by 300
In Vitro Models for Non-Alcoholic Fatty Liver Disease: Emerging Platforms and Their Applications
Ramos, M. J., Bandiera, L., Menolascina, F., & Fallowfield, J. A. (2022) · iScience · doi:10.1016/j.isci.2021.103549 · Cited by 127
Role of Oxidative Stress in Liver Disorders
Conde de la Rosa, L., Goicoechea, L., Torres, S., Garcia-Ruiz, C., & Fernandez-Checa, J. C. (2022) · Livers · doi:10.3390/livers2040023 · Cited by 107
Metadata
- Authors
- Kanda, T., Matsuoka, S., Yamazaki, M., Shibata, T., Nirei, K., Takahashi, H., Kaneko, T., Fujisawa, M., Higuchi, T., Nakamura, H., Matsumoto, N., Yamagami, H., Ogawa, M., Imazu, H., Kuroda, K., & Moriyama, M.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2018-07-07
- Volume
- 24
- Issue
- 25
- Pages
- 2661-2672
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2818331228
- Cited by
- 270
- References
- 125
- FWCI
- 17.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.